Abstract 7632: Plasma proteomics for risk prediction of lung cancer
Tej Pandya(University College Hospital), Charles Swanton(The Francis Crick Institute), Elizabeth A. Platz(Johns Hopkins University), Oleg Blyuss(University of Hertfordshire), Michelle Leung(CRUK Lung Cancer Centre of Excellence), Marcellus Augustine(The Francis Crick Institute), Maria Zagorulya(The Francis Crick Institute), Nuno R. Nené(The Francis Crick Institute), Ekaterina Pazukhina(Türkisch-Deutsche Universität), W. Hill(The Francis Crick Institute), Nicholas McGranahan(CRUK Lung Cancer Centre of Excellence), Clare E. Weeden(Walter and Eliza Hall Institute of Medical Research), Marc J. Gunter(Centre international de recherche sur le cancer), Marc R. Pelletier(American Institutes for Research), K. Smith-Byrne(Cancer Research UK Oxford Centre), David C. Muller(UNSW Sydney), Lydia Liu(CRUK Lung Cancer Centre of Excellence), Vernon A. Burk(Bloomberg (United States)), Neil Wright(University of Oxford), Eva Camilla Gronroos(The Francis Crick Institute), Ka Hung Chan(University of Oxford), Jincheng Wu(Medieval Academy of America)
Cited by 0
Related Papers
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
|Science|2016|3.1k
Energy balance and obesity: what are the main drivers?
|Cancer Causes & Control|2017|758
Lung adenocarcinoma promotion by air pollutants
|Nature|2023|751